Jump to Main Content
Increased mutability to fosfomycin resistance in Proteus mirabilis clinical isolates
- Fonseca, Marina R.B., Sato, Juliana L., Lima-Noronha, Marco A., Migliorini, Letícia B., Fernández-Silva, Frank S., Galhardo, Rodrigo S.
- Infection, genetics, and evolution 2018 v.58 pp. 27-33
- Proteus mirabilis, antibiotic resistance, fosfomycin, mutagenesis, mutants, rifampicin, risk
- In the present study, we screened a collection of 77 Proteus mirabilis clinical isolates for the presence of mutators, using the frequency of both rifampicin and fosfomycin resistance mutants as markers of spontaneous mutagenesis. We found that none of the strains in our collection are mutators for the rifampicin resistance (RifR) marker. Nevertheless, a significant fraction of the isolates (17%) show high frequencies of fosfomycin resistant mutants (FosR). We show that this increased mutability to FosR correlates with a low level of resistance to Fosfomycin (MICs 8–64μg/ml). These strains also show high frequencies of single step mutants with clinically relevant FosR resistance levels (MIC ≥256μg/ml). Our findings point out to the risk of fosfomycin resistance emergence in P. mirabilis.